HPV vaccine cut cervical cancer rates in England by 87%BMJ 2021; 375 doi: https://doi.org/10.1136/bmj.n2689 (Published 05 November 2021) Cite this as: BMJ 2021;375:n2689
- Ingrid Torjesen
The human papillomavirus vaccine has reduced the incidence of cervical cancer by 87% in women in their 20s in England who were offered the vaccine when they were aged 12-13 years as part of the UK HPV vaccination programme, a study published in the Lancet shows.1
Michelle Mitchell, chief executive of the charity Cancer Research UK, hailed the results as a “historic moment” that demonstrated the power of science.
The UK HPV vaccination programme was introduced in 2008, offering vaccines to girls aged 12-13, with a “catch-up” programme of vaccinations offered up to the age of 18.
The Lancet’s population based study used cancer registry data to compare the incidence of cervical cancer and non-invasive cervical carcinoma (CIN3) in seven cohorts of …